Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street ...

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech ETFs, they give sector participants exposure to many biotech companies via one ...

On February 5, Simeon Hyman, Global Investment Strategist at ProShares, appeared on a Schwab Network interview to discuss how investors can capitalize on market rotation. He noted that the mega-cap ...

The small‑cap tech sector — broadly companies often defined in the U.S. as those with market capitalizations under roughly $200 million to $2 billion — currently occupies a precarious yet potentially ...

Many small-cap companies are building and operating the data centers that provide the computing power for big tech's AI ambitions. In March 2024, Dell Technologies unveiled its “AI Factory with Nvidia ...

Wall Street is ending 2026 on a generally positive note, with the benchmark S&P 500 Index set to finish the year at a 17% return rate. All eyes are now on technology titans like Nvidia, Microsoft, ...

Vanguard Small-Cap ETF VB offers a well-diversified, low-turnover portfolio that is representative of the US small-cap market. These features, coupled with a minuscule fee, make it one of the best ...

Forbes contributors publish independent expert analyses and insights. Brett uses “second-level thinking” to find dividend stocks to buy. Late in 2025, I wrote about a “small-cap reawakening”—a bullish ...

Ben McPoland highlights a pair of UK small caps that have sold off heavily, making them worth considering for a Stocks and Shares ISA. The post 2 badly beaten-down small caps to consider for a £20,000 ...

For more than a decade, large caps have consistently outperformed small caps. The early performance of equities in 2026 demonstrates why small caps should be held as part of a diversified portfolio ...

Today's pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for COVID-19 vaccines and global stock market upheaval. However, the industry's major ...